Selective FKBP51 ligands for treatment of psychiatric disorders

Patent metadata

Field	Value
Publication number	US-10246413-B2
Application number	US-201715703056-A
Country	US
Kind code	B2
Filing date	Sep 13, 2017
Priority date	Sep 19, 2013
Publication date	Apr 2, 2019
Grant date	Apr 2, 2019

Abstract

The present invention relates to compounds having a selective FKBP51 ligand scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said selective FKBP51 ligand compounds can be used for prophylaxis and/or treatment of psychiatric disorders and neurodegenerative diseases, disorders and conditions.

First claim

The invention claimed is:

1. A compound of the general formula (I):

wherein:
X represents —CH 2 CH 2 ;
Y represents —O—;
Z represents a covalent bond;
R* represents —R**, —CH 2 —R**, —CH 2 —CH═CH 2 , -cyclo-C 6 H 11 , or -cyclo-C 5 H 9 ;
R** represents

R′ and R″ represent independently of each other —CH 3 , —C 2 H 5 , —CH(CH 3 ) 2 , —CH 2 CH═CH 2 , -cyclo-C 3 H 5 , or —C(CH 3 ) 3 ;
R A represents:

R B represents: —R 26 ,

R C represents: —R 27 ,

R D represents: —R 28 ,

R 1 -R 22 , R 18′ -R 22′ , R 26 -R 39 represent independently of each other —H, —OH, —OCH 3 , —OC 2 H 5 , —OC 3 H 7 , —O-cyclo-C 3 H 5 , —OCH(CH 3 ) 2 , —OC(CH 3 ) 3 , —OC 4 H 9 , —OCH 2 —COOH, —OPh, —OCH 2 -Ph, —OCPh 3 , —CH 2 —OH, —C 2 H 4 —OH, —C 3 H 6 —OH, —CH(OH)—CH 2 —OH, —CH 2 —OCH 3 , —C 2 H 4 —OCH 3 , —C 4 H 8 —OCH 3 , —C 3 H 6 —OCH 3 , —CH 2 —OC 2 H 5 , —C 2 H 4 —OC 2 H 5 , —C 3 H 6 —OC 2 H 5 , —C 4 H 8 —OC 2 H 5 , —CH 2 —OC 3 H 7 , —C 2 H 4 —OC 3 H 7 , —C 3 H 6 —OC 3 H 7 , —CH 2 —O-cyclo-C 3 H 5 , —C 2 H 4 —O-cyclo-C 3 H 5 , —C 3 H 6 —O-cyclo-C 3 H 5 , —C 4 H 8 —O-cyclo-C 3 H 5 , —CH 2 —OCH(CH 3 ) 2 , —C 2 H 4 —OCH(CH 3 ) 2 , —C 3 H 6 —OCH(CH 3 ) 2 , —C 4 H 8 —OCH(CH 3 ) 2 , —CH 2 —OC(CH 3 ) 3 , —C 2 H 4 —OC(CH 3 ) 3 , —C 3 H 6 —OC(CH 3 ) 3 , —C 4 H 8 —OC(CH 3 ) 3 , —CH 2 —OC 4 H 9 , —C 2 H 4 —OC 4 H 9 , —C 3 H 6 —OC 4 H 9 , —C 4 H 8 —OC 4 H 9 , —CH 2 —OPh, —C 2 H 4 —OPh, —C 3 H 6 —OPh, —C 4 H 8 —OPh, —CH 2 —OCH 2 -Ph, —C 2 H 4 —OCH 2 -Ph, —C 3 H 6 —OCH 2 -Ph, —C 4 H 8 —OCH 2 -Ph, —SH, —SCH 3 , —SC 2 H 5 , —SC 3 H 7 , —S-cyclo-C 3 H 5 , —SCH(CH 3 ) 2 , —SC(CH 3 ) 3 , —NO 2 , —F, —Cl, —Br, —I, —P(O)(OH) 2 , —P(O)(OCH 3 ) 2 , —P(O)(OC 2 H 5 ) 2 , —P(O)(OCH(CH 3 ) 2 ) 2 , —C(OH)[P(O)(OH) 2 ] 2 , —Si(CH 3 ) 2 (C(CH 3 ) 3 ), —Si(C 2 H 5 ) 3 , —Si(CH 3 ) 3 , —N 3 , —CN, —OCN, —NCO, —SCN, —NCS, —CHO, —COCH 3 , —COC 2 H 5 , —COC 3 H 7 , —CO-cyclo-C 3 H 5 , —COCH(CH 3 ) 2 , —COC(CH 3 ) 3 , —COOH, —COCN, —COOCH 3 , —COOC 2 H 5 , —COOC 3 H 7 , —COO-cyclo-C 3 H 5 , —COOCH(CH 3 ) 2 , —COOC(CH 3 ) 3 , —OOC—CH 3 , —OOC—C 2 H 5 , —OOC—C 3 H 7 , —OOC-cyclo-C 3 H 5 , —OOC—CH(CH 3 ) 2 , —OOC—C(CH 3 ) 3 , —CONH 2 , —CH 2 —CONH 2 , —CONHCH 3 , —CONHC 2 H 5 , —CONHC 3 H 7 , —CONH-cyclo-C 3 H 5 , —CONH[CH(CH 3 ) 2 ], —CONH[C(CH 3 ) 3 ], —CON(CH 3 ) 2 , —CON(C 2 H 5 ) 2 , —CON(C 3 H 7 ) 2 , —CON(cyclo-C 3 H 5 ) 2 , —CON[CH(CH 3 ) 2 ] 2 , —CON[C(CH 3 ) 3 ] 2 , —NHCOCH 3 , —NHCOC 2 H 5 , —NHCOC 3 H 7 , —NHCO-cyclo-C 3 H 5 , —NHCO—CH(CH 3 ) 2 , —NHCO—C(CH 3 ) 3 , —NHCO—OCH 3 , —NHCO—OC 2 H 5 , —NHCO—OC 3 H 7 , —NHCO—O-cyclo-C 3 H 5 , —NHCO—OCH(CH 3 ) 2 , —NHCO—OC(CH 3 ) 3 , —NH 2 , —NHCH 3 , —NHC 2 H 5 , —NHC 3 H 7 , —NH-cyclo-C 3 H 5 , —NHCH(CH 3 ) 2 , —NHC(CH 3 ) 3 , —N(CH 3 ) 2 , —N(C 2 H 5 ) 2 , —N(C 3 H 7 ) 2 , —N(cyclo-C 3 H 5 ) 2 , —N[CH(CH 3 ) 2 ] 2 , —N[C(CH 3 ) 3 ] 2 , —SOCH 3 , —SOC 2 H 5 , —SOC 3 H 7 , —SO-cyclo-C 3 H 5 , —SOCH(CH 3 ) 2 , —SOC(CH 3 ) 3 , —SO 2 CH 3 , —SO 2 C 2 H 5 , —SO 2 C 3 H 7 , —SO 2 -cyclo-C 3 H 5 , —SO 2 CH(CH 3 ) 2 , —SO 2 C(CH 3 ) 3 , —SO 3 H, —SO 3 CH 3 , —SO 3 C 2 H 5 , —SO 3 C 3 H 7 , —SO 3 -cyclo-C 3 H 5 , —SO 3 CH(CH 3 ) 2 , —SO 3 C(CH 3 ) 3 , —SO 2 NH 2 , —SO 2 NHCH 3 , —SO 2 NHC 2 H 5 , —SO 2 NHC 3 H 7 , —SO 2 NH-cyclo-C 3 H 5 , —SO 2 NHCH(CH 3 ) 2 , —SO 2 NHC(CH 3 ) 3 , —SO 2 N(CH 3 ) 2 , —SO 2 N(C 2 H 5 ) 2 , —SO 2 N(C 3 H 7 ) 2 , —SO 2 N(cyclo-C 3 H 5 ) 2 , —SO 2 N[CH(CH 3 ) 2 ] 2 , —SO 2 N[C(CH 3 ) 3 ] 2 , —O—S(═O)CH 3 , —O—S(═O)C 2 H 5 , —O—S(═O)C 3 H 7 , —O—S(═O)-cyclo-C 3 H 5 , —O—S(═O)CH(CH 3 ) 2 , —O—S(═O)C(CH 3 ) 3 , —S(═O)(═NH)CH 3 , —S(═O)(═NH)C 2 H 5 , —S(═O)(═NH)C 3 H 7 , —S(═O)(═NH)-cyclo-C 3 H 5 , —S(═O)(═NH)CH(CH 3 ) 2 , —S(═O)(═NH)C(CH 3 ) 3 , —NH—SO 2 —CH 3 , —NH—SO 2 —C 2 H 5 , —NH—SO 2 —C 3 H 7 , —NH—SO 2 -cyclo-C 3 H 5 , —NH—SO 2 —CH(CH 3 ) 2 , —NH—SO 2 —C(CH 3 ) 3 , —O—SO 2 —CH 3 , —O—SO 2 —C 2 H 5 , —O—SO 2 —C 3 H 7 , —O—SO 2 -cyclo-C 3 H 5 , —O—SO 2 —CH(CH 3 ) 2 , —O—SO 2 —C(CH 3 ) 3 , —OCF 3 , —CH 2 —OCF 3 , —C 2 H 4 —OCF 3 , —C 3 H 6 —OCF 3 , —OC 2 F5, —CH 2 —OC 2 F 5 , —C 2 H 4 —OC 2 F 5 , —C 3 H 6 —OC 2 F 5 , —O—COOCH 3 , —O—COOC 2 H 5 , —O—COOC 3 H 7 , —O—COO-cyclo-C 3 H 5 , —O—COOCH(CH 3 ) 2 , —O—COOC(CH 3 ) 3 , —NH—CO—NH 2 , —NH—CO—NHCH 3 , —NH—CO—NHC 2 H 5 , —NH—CS—N(C 3 H 7 ) 2 , —NH—CO—NHC 3 H 7 , —NH—CO—N(C 3 H 7 ) 2 , —NH—CO—NH[CH(CH 3 ) 2 ], —NH—CO—NH[C(CH 3 ) 3 ], —NH—CO—N(CH 3 ) 2 , —NH—CO—N(C 2 H 5 ) 2 , —NH—CO—NH-cyclo-C 3 H 5 , —NH—CO—N(cyclo-C 3 H 5 ) 2 , —NH—CO—N[CH(CH 3 ) 2 ] 2 , —NH—CS—N(C 2 H 5 ) 2 , —NH—CO—N[C(CH 3 ) 3 ] 2 , —NH—CS—NH 2 , —NH—CS—NHCH 3 , —NH—CS—N(CH 3 ) 2 , —NH—CS—NHC 2 H 5 , —NH—CS—NHC 3 H 7 , —NH—CS—NH-cyclo-C 3 H 5 , —NH—CS—NH[CH(CH 3 ) 2 ], —NH—CS—NH[C(CH 3 ) 3 ], —NH—CS—N(cyclo-C 3 H 5 ) 2 , —NH—CS—N[CH(CH 3 ) 2]2 , —NH—CS—N[C(CH 3 ) 3 ] 2 , —NH—C(═NH)—NH 2 , —NH—C(═NH)—NHCH 3 , —NH—C(═NH)—NHC 2 H 5 , —NH—C(═NH)—NHC 3 H 7 , —O—CO—NH-cyclo-C 3 H 5 , —NH—C(═NH)—NH-cyclo-C 3 H 5 , —NH—C(═NH)—NH[CH(CH 3 ) 2 ]—O—CO—NH[CH(CH 3 ) 2 ], —NH—C(═NH)—NH[C(CH 3 ) 3 ], —NH—C(═NH)—N(CH 3 ) 2 , —NH—C(═NH)—N(C 2 H 5 ) 2 , —NH—C(═NH)—N(C 3 H 7 ) 2 , —NH—C(═NH)—N(cyclo-C 3 H 5 ) 2 , —O—CO—NHC 3 H 7 , —NH—C(═NH)—N[CH(CH 3 ) 2 ] 2 , —NH—C(═NH)—N[C(CH 3 ) 3 ] 2 , —O—CO—NH 2 , —O—CO—NHCH 3 , —O—CO—NHC 2 H 5 , —O—CO—NH[C(CH 3 ) 3 ], —O—CO—N(CH 3 ) 2 , —O—CO—N(C 2 H 5 ) 2 , —O—CO—N(C 3 H 7 ) 2 , —O—CO—N(cyclo-C 3 H 5 ) 2 , —O—CO—N[CH(CH 3 ) 2 ] 2 , —O—CO—N[C(CH 3 ) 3]2 , —O—CO—OCH 3 , —O—CO—OC 2 H 5 , —O—CO—OC 3 H 7 , —O—CO—O-cyclo-C 3 H 5 , —O—CO—OCH(CH 3 ) 2 , —O—CO—OC(CH 3 ) 3 , —CH 2 F, —CHF 2 , —CF 3 , —CH 2 C 1 , —CH 2 Br, —CH 2 I, —CH 2 —CH 2 F, —CH 2 —CHF 2 , —CH 2 —CF 3 , —CH 2 —CH 2 C 1 , —CH 2 —CH 2 Br, —CH 2 —CH 2 I, -cyclo-C 5 H 9 , -cyclo-C 6 H 11 , —CH 2 -cyclo-C 6 H 11 , —CH 2 —CH 2 -cyclo-C 6 H 11 , -cyclo-C 7 H 13 , -cyclo-C 8 H 15 , -Ph, —CH 2 -Ph, —CH 2 —CH 2 -Ph, —CH═CH-Ph, —CPh 3 , —CH 3 , —C 2 H 5 , —C 3 H 7 , —CH(CH 3 ) 2 , —C 4 H 9 , —CH 2 —CH(CH 3 ) 2 , —CH(CH 3 )—C 2 H 5 , —C(CH 3 ) 3 , —C 5 H 11 , —CH(CH 3 )—C 3 H 7 , —CH 2 —CH(CH 3 )—C 2 H 5 , —CH(CH 3 )—CH(CH 3 ) 2 , —C(CH 3 ) 2 —C 2 H 5 , —CH 2 —C(CH 3 ) 3 , —CH(C 2 H 5 ) 2 , —C 2 H 4 —CH(CH 3 ) 2 , —C 6 H 13 , —C 7 H 15 , —C 8 H 17 , —C 3 H 6 —CH(CH 3 ) 2 , —C 2 H 4 —C

Assignees

• Max Planck Gesellschaft

Inventors

• Gaali Steffen
• Hausch Felix
• Kirschner Alexander
• Feng Xixi
• Bracher Andreas
• Ruehter Gerd

Classifications

• A61P37/00

  Drugs for immunological or allergic disorders · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A61P3/00

  Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title

• A61P25/00

  Drugs for disorders of the nervous system · CPC title

• C12N9/90

  Isomerases (5.) · CPC title